Merck Druggernaut
Merck Druggernaut
Regular price
Checking stock...
Regular price
Checking stock...
Summary
This volume offers an inside look at one of the most profitable pharmaceutical companies in the world. This story takes readers inside the Merck behemoth and discusses the company's highly successful methods, business style, and corporate philosophy.
The feel-good place to buy books
- Free US shipping over $15
- Buying preloved emits 41% less CO2 than new
- Millions of affordable books
- Give your books a new home - sell them back to us!

Merck Druggernaut by Fran Hawthorne
An in--depth look at big pharma's flagship company The Merck Druggernaut takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author Fran Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much--needed insight on the cutthroat world of pharmaceuticals. It's a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business's most recognizable names, The Merck Druggernaut takes a thoughtful look at some of the major issues of our time and the way those issues intertwine with the world of business. Fran Hawthorne (New York, NY) is the Assistant Managing Editor at Crain's New York Business. She has been covering business for more than twenty years for such publications as Fortune, BusinessWeek, and Institutional Investor, with a prevailing interest in healthcare and pharmaceuticals. At Crain's, she spearheads the publication of two to three special healthcare issues per year.
"Unlike some other critics, however, she understands and communicates the incredible complexity of discovering new drugs and introducing them to the market" (New York Times, March 23, 2003)
FRAN HAWTHORNE is a senior contributing editor of Institutional Investor and has connections deep within the business and finance communities. Hawthorne has been covering healthcare and business for more than twenty years for such publications as Fortune, BusinessWeek, and Crain's New York Business.
| SKU | Unavailable |
| ISBN 13 | 9780471228783 |
| ISBN 10 | 0471228788 |
| Title | Merck Druggernaut |
| Author | Fran Hawthorne |
| Condition | Unavailable |
| Binding Type | Hardback |
| Publisher | John Wiley and Sons Ltd |
| Year published | 2003-02-28 |
| Number of pages | 290 |
| Cover note | Book picture is for illustrative purposes only, actual binding, cover or edition may vary. |
| Note | Unavailable |